Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
about
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody PositivityThe impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome.Pro‑atherogenic activation of A7r5 cells induced by the oxLDL/β2GPI/anti‑β2GPI complex
P2860
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
@ast
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
@en
type
label
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
@ast
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
@en
prefLabel
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
@ast
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
@en
P2093
P2860
P356
P1476
Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
@en
P2093
APASS-WARSS Collaborators
Ann-Catherin C Simpson
Barbara C Tilley
Colum F Amory
Jay P Mohr
Mulugeta Gebregziabher
Robin L Brey
Stanley Tuhrim
Steven R Levine
P2860
P304
P356
10.1159/000441362
P577
2015-10-29T00:00:00Z